FI925787A7 - Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita - Google Patents
Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita Download PDFInfo
- Publication number
- FI925787A7 FI925787A7 FI925787A FI925787A FI925787A7 FI 925787 A7 FI925787 A7 FI 925787A7 FI 925787 A FI925787 A FI 925787A FI 925787 A FI925787 A FI 925787A FI 925787 A7 FI925787 A7 FI 925787A7
- Authority
- FI
- Finland
- Prior art keywords
- proteolytic enzymes
- saccharin derivative
- derivative inhibitors
- inhibitors
- saccharin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Beans For Foods Or Fodder (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Fertilizers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81026591A | 1991-12-19 | 1991-12-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI925787A0 FI925787A0 (fi) | 1992-12-18 |
| FI925787L FI925787L (fi) | 1993-06-20 |
| FI925787A7 true FI925787A7 (fi) | 1993-06-20 |
Family
ID=25203432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI925787A FI925787A7 (fi) | 1991-12-19 | 1992-12-18 | Proeteolyyttisten entsyymien sakkariinijohdannaisinhibiittoreita |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0547708B1 (enExample) |
| JP (1) | JP3179600B2 (enExample) |
| KR (2) | KR100292995B1 (enExample) |
| AT (1) | ATE233250T1 (enExample) |
| AU (1) | AU668694B2 (enExample) |
| CA (1) | CA2084857A1 (enExample) |
| CZ (1) | CZ283257B6 (enExample) |
| DE (1) | DE69232929D1 (enExample) |
| FI (1) | FI925787A7 (enExample) |
| HU (1) | HU219950B (enExample) |
| IL (1) | IL104154A (enExample) |
| MX (1) | MX9207449A (enExample) |
| MY (1) | MY110104A (enExample) |
| NO (1) | NO300770B1 (enExample) |
| NZ (1) | NZ245518A (enExample) |
| RU (1) | RU2107685C1 (enExample) |
| SG (1) | SG52659A1 (enExample) |
| SK (1) | SK374692A3 (enExample) |
| TW (1) | TW225532B (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378720A (en) * | 1991-12-19 | 1995-01-03 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
| US5541168A (en) * | 1994-12-02 | 1996-07-30 | Sterling Winthrop Inc. | Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| US5512576A (en) * | 1994-12-02 | 1996-04-30 | Sterling Winthrop Inc. | 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| DE19533643A1 (de) * | 1995-09-12 | 1997-03-13 | Nycomed Arzneimittel Gmbh | Neue cyclische Derivate von Benzolsulfonamiden |
| US5750550A (en) * | 1995-09-15 | 1998-05-12 | Sanofi | 2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof |
| US7998986B2 (en) | 2001-12-21 | 2011-08-16 | Exelixis Patent Company Llc | Modulators of LXR |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| AP1822A (en) | 2002-02-14 | 2008-01-30 | Pharmacia Corp | Substituted pyridinones as modulators of P38 MAP kinase. |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| WO2008040057A1 (en) * | 2006-10-04 | 2008-04-10 | Bionomics Limited | Novel benzofuran potassium channel blockers and uses thereof |
| US8048892B2 (en) | 2006-12-18 | 2011-11-01 | Amgen Inc. | Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| WO2008076427A2 (en) | 2006-12-18 | 2008-06-26 | Amgen Inc. | Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| ES2446418T3 (es) | 2007-04-18 | 2014-03-07 | Amgen, Inc | Derivados de indanona que inhiben la prolil hidroxilasa |
| EP2142509B1 (en) | 2007-04-18 | 2013-12-04 | Amgen, Inc | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| CA2685219C (en) | 2007-05-04 | 2012-06-19 | Amgen Inc. | Diazaquinolones that inhibit prolyl hydroxylase activity |
| US8030346B2 (en) | 2007-05-04 | 2011-10-04 | Amgen Inc. | Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity |
| EA017648B1 (ru) | 2007-09-14 | 2013-02-28 | Орто-Макнейл-Янссен Фармасьютикалз, Инк. | 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны |
| JP5547194B2 (ja) | 2008-09-02 | 2014-07-09 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | 代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体 |
| JP5690277B2 (ja) | 2008-11-28 | 2015-03-25 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体 |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| CN102439015B (zh) | 2009-05-12 | 2015-05-13 | 杨森制药有限公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途 |
| HRP20131122T1 (hr) | 2009-05-12 | 2013-12-20 | Janssen Pharmaceuticals, Inc. | Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja |
| JP5852664B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| ES2536433T3 (es) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
| EP2661435B1 (en) | 2010-11-08 | 2015-08-19 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| ME03518B (me) | 2014-01-21 | 2020-04-20 | Janssen Pharmaceutica Nv | Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena |
| PL3096790T3 (pl) | 2014-01-21 | 2020-01-31 | Janssen Pharmaceutica, N.V. | Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4195023A (en) * | 1975-08-20 | 1980-03-25 | Merck & Co., Inc. | 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin |
| US4276298A (en) * | 1978-03-24 | 1981-06-30 | Merck & Co., Inc. | 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors |
| DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
| KR0183397B1 (ko) * | 1989-05-04 | 1999-05-01 | 존 엠. 스피나토 | 단백질 분해 효소 저해제로서 유용한 사카린 유도체들 및 그의 제조방법 |
| AU642537B2 (en) * | 1990-11-01 | 1993-10-21 | Sanofi | 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| AU656027B2 (en) * | 1991-11-15 | 1995-01-19 | Sanofi | Saccharin derivative proteolytic enzime inhibitors |
-
1992
- 1992-11-12 AU AU28292/92A patent/AU668694B2/en not_active Ceased
- 1992-11-18 TW TW081109245A patent/TW225532B/zh active
- 1992-12-08 CA CA002084857A patent/CA2084857A1/en not_active Abandoned
- 1992-12-11 MY MYPI92002285A patent/MY110104A/en unknown
- 1992-12-15 DE DE69232929T patent/DE69232929D1/de not_active Expired - Lifetime
- 1992-12-15 AT AT92203917T patent/ATE233250T1/de not_active IP Right Cessation
- 1992-12-15 SG SG1996007465A patent/SG52659A1/en unknown
- 1992-12-15 EP EP92203917A patent/EP0547708B1/en not_active Expired - Lifetime
- 1992-12-17 KR KR1019920024707A patent/KR100292995B1/ko not_active Expired - Fee Related
- 1992-12-17 JP JP33703492A patent/JP3179600B2/ja not_active Expired - Fee Related
- 1992-12-18 HU HU9204029A patent/HU219950B/hu not_active IP Right Cessation
- 1992-12-18 NZ NZ245518A patent/NZ245518A/en unknown
- 1992-12-18 CZ CS923746A patent/CZ283257B6/cs not_active IP Right Cessation
- 1992-12-18 IL IL10415492A patent/IL104154A/en not_active IP Right Cessation
- 1992-12-18 MX MX9207449A patent/MX9207449A/es not_active IP Right Cessation
- 1992-12-18 RU RU92016244A patent/RU2107685C1/ru not_active IP Right Cessation
- 1992-12-18 SK SK3746-92A patent/SK374692A3/sk unknown
- 1992-12-18 NO NO924915A patent/NO300770B1/no unknown
- 1992-12-18 FI FI925787A patent/FI925787A7/fi unknown
-
2000
- 2000-10-20 KR KR1020000061842A patent/KR100378968B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU9204029D0 (en) | 1993-04-28 |
| EP0547708A1 (en) | 1993-06-23 |
| KR100378968B1 (ko) | 2003-04-08 |
| SK278390B6 (en) | 1997-02-05 |
| JP3179600B2 (ja) | 2001-06-25 |
| NO300770B1 (no) | 1997-07-21 |
| NO924915L (no) | 1993-06-21 |
| IL104154A (en) | 1996-09-12 |
| AU668694B2 (en) | 1996-05-16 |
| IL104154A0 (en) | 1993-05-13 |
| ATE233250T1 (de) | 2003-03-15 |
| SG52659A1 (en) | 1998-09-28 |
| DE69232929D1 (de) | 2003-04-03 |
| NO924915D0 (no) | 1992-12-18 |
| CA2084857A1 (en) | 1993-06-20 |
| MX9207449A (es) | 1994-03-31 |
| RU2107685C1 (ru) | 1998-03-27 |
| MY110104A (en) | 1998-01-27 |
| HUT67039A (en) | 1995-01-30 |
| FI925787A0 (fi) | 1992-12-18 |
| FI925787L (fi) | 1993-06-20 |
| JPH05345771A (ja) | 1993-12-27 |
| KR100292995B1 (ko) | 2001-09-17 |
| HU219950B (hu) | 2001-09-28 |
| TW225532B (enExample) | 1994-06-21 |
| EP0547708B1 (en) | 2003-02-26 |
| CZ374692A3 (en) | 1993-08-11 |
| SK374692A3 (en) | 1997-02-05 |
| AU2829292A (en) | 1993-07-08 |
| NZ245518A (en) | 1995-06-27 |
| CZ283257B6 (cs) | 1998-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI942423A7 (fi) | Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina | |
| FI925167A7 (fi) | 2-substituoituja sakkariinijohdannaisia, jotka ovat proteolyyttisten entsyymien inhibiittoreita | |
| FI933277A7 (fi) | Amiinidioli proteaasi-inhibiittorit | |
| DE69226820D1 (de) | Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen | |
| FI913788A7 (fi) | Seriiniproteaasien inhibiittoreita | |
| MC2313A1 (fr) | Inhibiteurs d'enzymes | |
| FI20085256L (fi) | Retrovirusperäisten proteaasi-inhibiittoreiden yhdistelmä | |
| DK70491D0 (da) | Heterocyklisk renininhibitorer | |
| NO962269D0 (no) | Enzyminhibitorer | |
| DK674387A (da) | Proteaseinhibitorer | |
| NO20006717D0 (no) | Proteaseinhibitorer | |
| FI941766A7 (fi) | sPLA2:n 1H-indoli-3-etikkahappohydratsidi-inhibiittoreita | |
| FI950841L (fi) | Retrovirusproteaasi-inhibiittoreina käyttökelpoisia N-(alkanoyyliamino-2-hydroksipropyyli)-sulfoniamideja | |
| FI943234A0 (fi) | Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos | |
| FI942625A7 (fi) | Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina | |
| FI971784A0 (fi) | Apolipoproteiini B-synteesin estäjiä | |
| EE04241B1 (et) | Apolipoproteiin-B sünteesi inhibiitorid | |
| MX9100998A (es) | Novedosos inhibidores de escualen sintetasa | |
| FI895962A7 (fi) | Proteaasi-inhibiittorit | |
| DK349586A (da) | Enzyminhibitor | |
| AU656027B2 (en) | Saccharin derivative proteolytic enzime inhibitors | |
| FI962235L (fi) | Uudet bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina | |
| MX9100121A (es) | Inhibidores de proteasas asparticas | |
| FI962236L (fi) | Heterosykliset bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina | |
| NO921673L (no) | Inhibitor av laminin-neurittaktiverende aktivitet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: SANOFI |